Gene: CYREN
Official Full Name: cell cycle regulator of NHEJprovided by HGNC
Gene Summary: Predicted to enable molecular adaptor activity. Involved in double-strand break repair via nonhomologous end joining and negative regulation of double-strand break repair via nonhomologous end joining. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18425 | CYREN Knockout cell line (HeLa) | Human | CYREN | 1:3~1:6 | Negative | Online Inquiry |
KO18426 | CYREN Knockout cell line (HCT 116) | Human | CYREN | 1:2~1:4 | Negative | Online Inquiry |
KO18427 | CYREN Knockout cell line (HEK293) | Human | CYREN | 1:3~1:6 | Negative | Online Inquiry |
KO18428 | CYREN Knockout cell line (A549) | Human | CYREN | 1:3~1:4 | Negative | Online Inquiry |
CYREN Gene Knockout Cell Lines are a cutting-edge resource designed to facilitate gene function studies, drug discovery, and therapeutic development. These engineered cell lines are constructed using precise CRISPR-Cas9 gene editing technology, enabling the specific deletion of targeted genes. This knockout approach allows researchers to investigate the effects of gene loss on cellular physiology, signaling pathways, and overall cellular behavior, thus providing a vital tool for understanding gene function in various biological contexts.
The key functions of CYREN Gene Knockout Cell Lines lie in their ability to mimic physiological conditions in in vivo models, providing an accurate representation of gene function. Upon introduction into experimental setups, these knockout lines can elucidate the role of specific genes in disease mechanisms, drug resistance, or metabolic pathways, making them invaluable in both basic research and applied sciences. The mechanism of action hinges on the efficient disruption of target genes, thus allowing for downstream analyses—including transcriptomic and proteomic evaluations—that could lead to novel therapeutic insights.
From a scientific standpoint, CYREN Gene Knockout Cell Lines are critical in advancing our understanding of complex diseases such as cancer, neurodegenerative disorders, and metabolic syndromes. Their applications extend to studying gene interactions, validating drug targets, and screening for drug efficacy. By providing a reliable platform for functional genomics, these cell lines significantly enhance experimental reproducibility and data reliability.
When compared to traditional knockout models, such as those derived from homologous recombination, CYREN’s offerings are characterized by rapid generation times, improved precision, and reduced costs. Furthermore, their ready-to-use nature minimizes laboratory work, allowing researchers to focus more on results rather than extensive developmental phases.
Researchers and clinicians looking to advance their investigations will find CYREN Gene Knockout Cell Lines a pivotal resource in unlocking biological mysteries and driving innovation in therapeutic strategies. Our company leverages extensive expertise in genetic engineering and cell biology, ensuring that our products meet the highest standards of quality and performance, thereby empowering the scientific community to achieve groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.